Name
Novaviva OÜ
Registry code
10203603
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
24.03.1997 (27)
Financial year
01.01-31.12
Capital
2 500.00 €
Activity
68201 - Rental and operating of own or leased real estate
48 847 €
997 391 €
2042%
-
3 289 448 €
0
Submitted
No tax arrears
30%
28%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Ivar Lindla 10.01.1968 (56) | 100% - 2 500.00 EUR | Board member | Direct ownership | Founder |
| Marko Kalle 27.11.1966 (57) | - | - | - | Founder |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| AB Medical Group Eesti osaühing 10234070 | 50% - 3 195.00 EUR | - | - | |
| Keeni Mõis OÜ 12777372 | 100% - 2 500.00 EUR | - | - | Founder |
| OÜ Läätsed.ee 12184293 | 50% - 1 250.00 EUR | - | - |
| 2019 08.10.2020 | 2020 27.04.2022 | 2021 14.06.2022 | 2022 29.06.2023 | 2023 30.04.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 23 160 € | 27 567 € | 40 742 € | 41 621 € | 48 847 € |
| Net profit (loss) for the period | 590 184 € | 525 662 € | 611 994 € | 592 687 € | 997 391 € |
| Profit Margin | 2548% | 1907% | 1502% | 1424% | 2042% |
| Current Assets | 299 708 € | 435 311 € | 423 390 € | 483 605 € | 154 092 € |
| Fixed Assets | 1 736 046 € | 1 744 877 € | 2 092 122 € | 2 245 345 € | 3 449 621 € |
| Total Assets | 2 035 754 € | 2 180 188 € | 2 515 512 € | 2 728 950 € | 3 603 713 € |
| Current Liabilities | 7 678 € | 2 490 € | 314 142 € | 278 893 € | 314 265 € |
| Non Current Liabilities | 313 321 € | 309 821 € | 0 € | - | - |
| Total Liabilities | 320 999 € | 312 311 € | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 1 714 755 € | 1 867 877 € | 2 201 370 € | 2 450 057 € | 3 289 448 € |
| Employees | 0 | 0 | 0 | 0 | 0 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2023 Q4 | - | 148.75 € | - | - |
| 2023 Q1 | - | 241.1 € | - | - |
| 2022 Q4 | - | 148.75 € | - | - |
| 2022 Q1 | - | 241.1 € | - | - |
| 2021 Q4 | - | 166.12 € | - | - |
| 2021 Q1 | - | 258.48 € | - | - |
| 2020 Q4 | - | 166.12 € | - | - |
| 2020 Q1 | - | 258.48 € | - | - |
